Optimising Human Mesenchymal Stem Cell Numbers for Clinical Application: A Literature Review

Adult mesenchymal stem cells (MSCs) are being investigated further for their use in stem cell therapies. However, as they are found in very low numbers in adult tissue, expansion in vitro is required to produce desired MSC numbers for clinical application. The need for effective cell-based therapies...

Full description

Bibliographic Details
Main Authors: E. Fossett, W. S. Khan
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2012/465259
id doaj-5265cbd93d2c44b48b7fce87c4cd66cb
record_format Article
spelling doaj-5265cbd93d2c44b48b7fce87c4cd66cb2020-11-24T22:41:34ZengHindawi LimitedStem Cells International1687-966X1687-96782012-01-01201210.1155/2012/465259465259Optimising Human Mesenchymal Stem Cell Numbers for Clinical Application: A Literature ReviewE. Fossett0W. S. Khan1University College London Institute for Orthopaedics and Musculoskeletal Sciences, Royal National Orthopaedic Hospital, Stanmore HA7 4LP, UKUniversity College London Institute for Orthopaedics and Musculoskeletal Sciences, Royal National Orthopaedic Hospital, Stanmore HA7 4LP, UKAdult mesenchymal stem cells (MSCs) are being investigated further for their use in stem cell therapies. However, as they are found in very low numbers in adult tissue, expansion in vitro is required to produce desired MSC numbers for clinical application. The need for effective cell-based therapies is increasing due to a rise in the ageing population, increasing the prevalence of musculoskeletal disorders. This review investigates how factors, age and gender of donor, as well as seeding density can affect MSC expansion. Age and gender of donor have received mixed results from studies, whereas seeding density studies have produced consistent results for numerous MSC sources, favouring lower seeding densities. Further research is required to reduce the risk of infection, loss of cell characterisation in cell culture, and making cell-based therapies more cost effective through creating rapid expansion of MSCs regardless of patient factors.http://dx.doi.org/10.1155/2012/465259
collection DOAJ
language English
format Article
sources DOAJ
author E. Fossett
W. S. Khan
spellingShingle E. Fossett
W. S. Khan
Optimising Human Mesenchymal Stem Cell Numbers for Clinical Application: A Literature Review
Stem Cells International
author_facet E. Fossett
W. S. Khan
author_sort E. Fossett
title Optimising Human Mesenchymal Stem Cell Numbers for Clinical Application: A Literature Review
title_short Optimising Human Mesenchymal Stem Cell Numbers for Clinical Application: A Literature Review
title_full Optimising Human Mesenchymal Stem Cell Numbers for Clinical Application: A Literature Review
title_fullStr Optimising Human Mesenchymal Stem Cell Numbers for Clinical Application: A Literature Review
title_full_unstemmed Optimising Human Mesenchymal Stem Cell Numbers for Clinical Application: A Literature Review
title_sort optimising human mesenchymal stem cell numbers for clinical application: a literature review
publisher Hindawi Limited
series Stem Cells International
issn 1687-966X
1687-9678
publishDate 2012-01-01
description Adult mesenchymal stem cells (MSCs) are being investigated further for their use in stem cell therapies. However, as they are found in very low numbers in adult tissue, expansion in vitro is required to produce desired MSC numbers for clinical application. The need for effective cell-based therapies is increasing due to a rise in the ageing population, increasing the prevalence of musculoskeletal disorders. This review investigates how factors, age and gender of donor, as well as seeding density can affect MSC expansion. Age and gender of donor have received mixed results from studies, whereas seeding density studies have produced consistent results for numerous MSC sources, favouring lower seeding densities. Further research is required to reduce the risk of infection, loss of cell characterisation in cell culture, and making cell-based therapies more cost effective through creating rapid expansion of MSCs regardless of patient factors.
url http://dx.doi.org/10.1155/2012/465259
work_keys_str_mv AT efossett optimisinghumanmesenchymalstemcellnumbersforclinicalapplicationaliteraturereview
AT wskhan optimisinghumanmesenchymalstemcellnumbersforclinicalapplicationaliteraturereview
_version_ 1725701814085484544